Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$58M |
| 2 |
Wells Fargo
WFC
|
+$39.8M |
| 3 |
Northrop Grumman
NOC
|
+$39.6M |
| 4 |
Pfizer
PFE
|
+$37.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$33.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$59.8M |
| 2 |
Cigna
CI
|
+$42M |
| 3 |
Altria Group
MO
|
+$28.5M |
| 4 |
Philip Morris
PM
|
+$28.3M |
| 5 |
Parker-Hannifin
PH
|
+$26.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Industrials | 18.96% |
| 3 | Consumer Discretionary | 15.28% |
| 4 | Healthcare | 13.64% |
| 5 | Consumer Staples | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Wabash National
WNC
$486M
| $1.49M | 0.02% |
109,761
+14,981
| +16% | +$212K |
|
552
GE Aerospace
GE
$354B
| $1.47M | 0.02% |
29,563
-88,994
| -75% | -$4.19M |
|
553
Vulcan Materials
VMC
$35.6B
| $1.47M | 0.02% |
+12,415
| New | +$1.34M |
|
554
Charles River Laboratories
CRL
$14B
| $1.47M | 0.02% |
10,111
-23,794
| -70% | -$3.13M |
|
555
Capital One
COF
$133B
| $1.46M | 0.02% |
17,832
+12,871
| +259% | +$1.05M |
|
556
M&T Bank
MTB
$34.8B
| $1.45M | 0.02% |
+9,248
| New | +$1.52M |
|
557
Genesco
GCO
$388M
| $1.45M | 0.02% |
31,853
+25,135
| +374% | +$1.15M |
|
558
Travelers Companies
TRV
$77.1B
| $1.45M | 0.02% |
10,578
+1,955
| +23% | +$250K |
|
559
United Therapeutics
UTHR
$21.9B
| $1.45M | 0.02% |
12,355
-18,572
| -60% | -$2.16M |
|
560
Quanta Services
PWR
$92.8B
| $1.44M | 0.02% |
+38,158
| New | +$1.33M |
|
561
Oshkosh
OSK
$9.63B
| $1.43M | 0.02% |
19,088
-235,861
| -93% | -$17.4M |
|
562
Jabil
JBL
$31.8B
| $1.43M | 0.02% |
+53,892
| New | +$1.44M |
|
563
Goodyear
GT
$1.7B
| $1.43M | 0.02% |
78,844
-344,273
| -81% | -$6.7M |
|
|
NXGN
564
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.42M | 0.02% |
84,430
-10,674
| -11% | -$185K |
|
565
Copart
CPRT
$30.9B
| $1.42M | 0.02% |
93,452
-4
| -0% | -$54 |
|
566
Allstate
ALL
$65.6B
| $1.42M | 0.02% |
15,025
+12,214
| +435% | +$1.1M |
|
|
PPL
567
PPL Corp
PPL
$26.3B
| $1.4M | 0.02% |
44,176
+17,463
| +65% | +$543K |
|
|
CTB
568
DELISTED
Cooper Tire & Rubber Co.
CTB
| $1.4M | 0.02% |
46,899
-58
| -0.1% | -$1.86K |
|
569
Verisk Analytics
VRSK
$24.7B
| $1.39M | 0.02% |
10,412
-5,557
| -35% | -$676K |
|
570
Expedia Group
EXPE
$40B
| $1.38M | 0.02% |
11,569
-16,670
| -59% | -$2.02M |
|
571
UDR
UDR
$12.2B
| $1.38M | 0.02% |
30,243
-24,798
| -45% | -$1.08M |
|
572
Installed Building Products
IBP
$6.48B
| $1.37M | 0.02% |
28,273
-26,771
| -49% | -$1.15M |
|
573
Generac Holdings
GNRC
$11.9B
| $1.37M | 0.02% |
26,707
-10,926
| -29% | -$570K |
|
574
Corcept Therapeutics
CORT
$13.2B
| $1.36M | 0.02% |
115,829
-6,964
| -6% | -$86.5K |
|
|
HSII
575
DELISTED
Heidrick & Struggles
HSII
| $1.36M | 0.02% |
35,420
-1,894
| -5% | -$68.3K |
|
Similar funds
Joel Greenblatt's Q1 2019 Portfolio in Review
As of Q1 2019, Joel Greenblatt held 1,284 positions worth $6.83B, up 6.1% from $6.44B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Joel Greenblatt withdrew a net $437M in Q1 2019, closing 124 positions and reducing 485 holdings. Its most notable exit was Cigna, an estimated $42M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Joel Greenblatt opened a new position in General Dynamics worth $58.2M.
- Joel Greenblatt's largest Q1 2019 buy was General Dynamics: 343,980 shares worth $58.2M.
- Joel Greenblatt added most to Wells Fargo in Q1 2019, an estimated $39.8M increase.
- Joel Greenblatt's biggest Q1 2019 reduction was RTX Corp, cutting an estimated $59.8M.
- Joel Greenblatt fully exited Cigna in Q1 2019, selling an estimated $42M.
- Joel Greenblatt's ten largest holdings make up 10% of its $6.83B portfolio in Q1 2019.
- Joel Greenblatt opened 319 new positions and closed 124 in Q1 2019.
- Joel Greenblatt's portfolio value rose 6.1% quarter-over-quarter to $6.83B.
Based on Gotham Asset Management's 13F filing for Q1 2019, filed 15 May 2019.